[Indication for selective surgical excision of hepatic metastases].
451 patients undergoing surgery for colorectal cancer showed synchronous hepatic metastases in 24.4% (110 cases). Survival of patients with hepatic metastases appears to depend on both the age of the patient and the site of metastatic deposit. A relatively good prognosis group with median survival of 14 months can be separated from the other patients with only 5 months survival. Survival of patients with hepatic metastases can thus be predicted and long-term survival (5 and 10 years) obtained by surgical excision of these metastases. Postoperative CEA determinations will also increase the rate of early surgery for hepatic metastases.
D000328:Adult; D000368:Aged; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003110:Colonic Neoplasms / Q000601:surgery; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery*; D008722:Methods; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011182:Postoperative Care; D011379:Prognosis; D012004:Rectal Neoplasms / Q000601:surgery; D013997:Time Factors
D002272:Carcinoembryonic Antigen
Indication sélective à l'exérèse chirurgicale des métastases hépatiques.